In this video Dr. Fahy discusses the TRIIM-X trial, which is the follow on to the original TRIIM trial. We discuss the differences from TRIIM and the current state of the trial. It is still open for enrolment!
Dr. Greg Fahy is a world renowned cryobiologist and is also the chief science officer, and co-founder, of Intervene Immune, a company which pioneers treatments for thymus regeneration and age-related immune system decline. Dr. Fahy Designed and led the pilot TRIIM trial which first time showing both thymus rejuvenation and reversal of human epigenetic age. He is now running the follow up phase II trial TRIIM-X with the aim of confirming and extending the results.
Modern Healthspan